..
work in progress, more to come!! . . . → Read More: Yes ..
|
|||||
|
Estimated turn-around: 12-15 days * A simple overnight urine specimen; no blood draw is necessary! * Order this profile by itself or get a special discount when you order it as an add-on with: Organix Profiles, ION Profiles, Cardio/ION Profile, TRIAD Profile, or Toxic Effects Porphyrins Profile. . . . → Read More: Metametrix 0088 Neopterin/Biopterin Profile Estimated turn-around: 15-20 days * A simple first-morning urine specimen; no blood draw is necessary. * Economical, so you can retest often to monitor therapy. * Bone Resorption Test can be added for osteoporosis risk assessment at only a small incremental cost. . . . → Read More: Metametrix 0145 EstronexSM – 2/16 with Bone Resorption Estimated turn-around: 15-20 days * A simple first-morning urine specimen; no blood draw is necessary. * Economical, so you can retest often to monitor therapy. * Bone Resorption Test can be added for osteoporosis risk assessment at only a small incremental cost.N . . . → Read More: Metametrix 0145 EstronexSM – 2/16 with Bone Resorption Estimated turn-around: 15-20 days * A simple first-morning urine specimen; no blood draw is necessary. * Economical, so you can retest often to monitor therapy. * Bone Resorption Test can be added for osteoporosis risk assessment at only a small incremental cost. . . . → Read More: Metametrix 0142 EstronexSM – 2/16 OH Estrogen Ratio Estimated turn-around: 10-15 days Accelerated bone loss affects more than 44 million Americans 50 years of age and older. 80% of them are women. But men, younger women, and otherwise healthy, active individuals can also experience the dangerous thinning and weakening of bones associated with osteoporosis. The Bone Resorption Assay can not only identify individuals at risk, but also monitor the effect of your therapeutic interventions. . . . → Read More: Metametrix 0018 Bone Resorption – Deoxypyridinoline Estimated turn-around: ## days Elevated ADMA has been associated with various cardiovascular risk factors, renal failure, and erectile dysfunction. Factors contributing to elevated ADMA include increased oxidative challenge and folic acid insufficiency . . . → Read More: Metametrix 0014 ADMA (Asymmetric Dimethylarginine) – Plasma Estimated turn-around: ## days The Cardiovascular Health Profile combines innovative nutritional and metabolic markers, along with conventional blood lipids to provide a comprehensive risk assessment of cardiovascular disease (CVD). . . . → Read More: Metametrix 0161 Cardiovascular Health – Blood Estimated turn-around: 12-15 days * Central obesity (Increased waist to hip ratio due to excessive fat tissue in and around the abdomen) * Raised blood pressure (130/85 mmHg or higher) * Dyslipidemia (Mainly high triglycerides and low HDL) * Insulin resistance (Hyperinsulinemia) * Proinflammatory state (Elevated plasma AA/EPA ratio) . . . → Read More: Metametrix 0146 Metabolic Syndrome Profile |
|||||
|
Copyright © 2012 Pacific Wellspring - All Rights Reserved |
|||||